EV/EBITDA
-0.56
0.000.00%
Thu, 28 Nov 2024 00:58:14 GMT
Summary:
Editas Medicine EV/EBITDA is currently -0.56, unchanged from the previous trading day. Over the past year, it has increased by +3.50 (+86.21%). EDIT EV/EBITDA is now at all-time high.EDIT EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EDIT EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | 0.0% |
| 1 m1 month | +41.7% |
| 3 m3 months | +60.0% |
| 6 m6 months | +77.0% |
| ytdytd | +87.7% |
| 1 y1 year | +86.2% |
| 5 y5 years | +95.0% |
EDIT EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -0.56 | at high | -0.97 | +42.3% |
| 3 m | 3 months | -0.56 | at high | -1.46 | +61.6% |
| 6 m | 6 months | -0.56 | at high | -2.58 | +78.3% |
| 1 y | 1 year | -0.56 | at high | -5.12 | +89.1% |
| 3 y | 3 years | -0.56 | at high | -9.42 | +94.1% |
| 5 y | 5 years | -0.56 | at high | -47.74 | +98.8% |
| alltime | all time | -0.56 | at high | -47.74 | +98.8% |
Editas Medicine EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -0.56(-87.7%) |
| 2023 | -4.54(+94.0%) |
| 2022 | -2.34(-73.2%) |
| 2021 | -8.72(-73.3%) |
| Date | Value |
|---|---|
| 2020 | -32.65(+222.0%) |
| 2019 | -10.14(+11.3%) |
| 2018 | -9.11(-15.8%) |
| 2017 | -10.82(+135.7%) |
| 2016 | -4.59 |
FAQ
- What is Editas Medicine EV/EBITDA?
- What is the all time high EV/EBITDA for Editas Medicine?
- What is EDIT EV/EBITDA year-to-date change?
- What is Editas Medicine EV/EBITDA year-on-year change?
What is Editas Medicine EV/EBITDA?
The current EV/EBITDA of EDIT is -0.56
What is the all time high EV/EBITDA for Editas Medicine?
Editas Medicine all-time high EV/EBITDA is -0.56
What is EDIT EV/EBITDA year-to-date change?
Editas Medicine EV/EBITDA has changed by +3.98 (+87.67%) since the beginning of the year
What is Editas Medicine EV/EBITDA year-on-year change?
Over the past year, EDIT EV/EBITDA has changed by +3.50 (+86.21%)